Divi's Laboratories Ltd.
|
Income Statement
|
|
You can view the
Income Statement
for the last 5 years.
Market Cap. (Rs.)
|
160555.40 Cr.
|
P/BV
|
11.70
|
Book Value (Rs.)
|
516.71
|
52 Week High/Low (Rs.)
|
6309/3724
|
FV/ML
|
2/1
|
P/E(X)
|
100.35
|
Bookclosure
|
02/08/2024
|
EPS (Rs.)
|
60.27
|
Div Yield (%)
|
0.50
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 7796.00 | 7665.94 | 8799.23 | 6858.34 | 5291.17 |
Other Operating Revenues | 49.00 | 101.57 | 160.60 | 111.06 | 103.25 |
Total Operating Revenues | 7845.00 | 7767.51 | 8959.83 | 6969.40 | 5394.42 |
| | | | | |
Other Income | 339.00 | 344.66 | 113.87 | 62.56 | 189.63 |
Total Revenue | 8184.00 | 8112.17 | 9073.70 | 7031.96 | 5584.05 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 3232.00 | 3008.36 | 3476.56 | 2397.44 | 2198.41 |
Purchase Of Stock-In Trade | 6.00 | 22.33 | 14.41 | 5.31 | 16.11 |
Changes In Inventories Of FG,WIP And Stock-In Trade | -109.00 | 23.03 | -523.83 | -78.67 | -105.98 |
Employee Benefit Expenses | 1094.00 | 975.02 | 946.16 | 825.76 | 621.05 |
Finance Costs | 3.00 | 0.67 | 0.80 | 0.87 | 6.10 |
Depreciation And Amortisation Expenses | 378.00 | 343.18 | 311.51 | 255.59 | 186.24 |
Other Expenses | 1417.00 | 1370.95 | 1164.59 | 959.62 | 842.66 |
Total Expenses | 6021.00 | 5743.54 | 5390.20 | 4365.92 | 3764.59 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 2163.00 | 2368.63 | 3683.50 | 2666.04 | 1819.46 |
| | | | | |
Profit/Loss Before Tax | 2163.00 | 2368.63 | 3683.50 | 2666.04 | 1819.46 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | 514.00 | 439.17 | 644.00 | 616.46 | 392.79 |
Deferred Tax | 49.00 | 106.08 | 79.05 | 65.29 | 50.13 |
Total Tax Expenses | 563.00 | 545.25 | 723.05 | 681.75 | 442.92 |
Profit/Loss After Tax And Before ExtraOrdinary Items | 1600.00 | 1823.38 | 2960.45 | 1984.29 | 1376.54 |
| | | | | |
Profit/Loss From Continuing Operations | 1600.00 | 1823.38 | 2960.45 | 1984.29 | 1376.54 |
| | | | | |
Profit/Loss For The Period | 1600.00 | 1823.38 | 2960.45 | 1984.29 | 1376.54 |
Consolidated Profit/Loss After MI And Associates | 1600.00 | 1823.38 | 2960.45 | 1984.29 | 1376.54 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | 60.27 | 68.69 | 111.52 | 74.75 | 51.85 |
Diluted EPS (Rs.) | 60.27 | 68.69 | 111.52 | 74.75 | 51.85 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 796.00 | 796.41 | 530.94 | 0.00 | 1024.12 |